Guardion Health Sciences Inc. (NASDAQ:GHSI) does about 5.55M shares in volume on a normal day but saw 3401980 shares change hands in Tuesday trading. The company now has a market cap of 28.14M USD. Its current market price is $0.29, marking a decrease of -7.61% compared to the previous close of $0.31. The 52 week high reached by this stock is $0.95 whilst the lowest price level in 52 weeks is $0.17. The script in recent trading has seen the stock touch a high of $0.3089 and a low of $0.2851.

Guardion Health Sciences Inc. (GHSI) has a 20-day trading average at $0.3559 and the current price is -69.47% off the 52-week high compared with 75.76% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.4045 and its 200-day simple moving average is $0.3747. If we look at the stock’s price movements over the week, volatility stands at 9.10%, which decreases to 9.02% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 33.53 to suggest the stock is neutral.

The current price level is -19.75%, -28.82%, and -22.54% away from its SMA20, SMA50, and SMA200 respectively, with the GHSI price moving above the 50-day SMA on September 01. Guardion Health Sciences Inc. (GHSI) stock is down -13.97% over the week and -28.40% over the past month. Its price is 31.63% year-to-date and 12.40% over the past year.

Outstanding shares total 86.57M with insiders holding 7.23% of the shares and institutional holders owning 3.54% of the company’s common stock. The company has a return on investment of -87.50% and return on equity of -81.70%. Price to book ratio is 1.93 and price to sales ratio is 15.64.

Vanguard Total Stock Market Index isn’t the only investment manager who changed stakes and is followed by Vanguard Extended Market Index Fu, which sold off 0.0 shares to end up with 688,575 shares worth $0.29 million. Fidelity Extended Market Index Fu cut their holdings by 0.00% in the company over the course of the most recent quarter. It now holds a 0.32% position in Guardion Health Sciences Inc. thanks to 0.27 million shares amounting to $0.12 million.